deltatrials
Unknown OBSERVATIONAL NCT03425994

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (Genvoya) as Maintenance Treatment of HIV-1/Hepatitis B Virus (HBV)-Coinfected Patients: an Observational Study

Sponsor: Chang Gung Memorial Hospital

Conditions Bone Diseases Chronic Hepatitis B in HIV Patient Kidney Injury
Interventions Elvitegravir/Cobicistat/Emtricitabine
Updated 12 times since 2018 Last updated: Aug 25, 2019 Started: Feb 6, 2018 Primary completion: Feb 22, 2019 Completion: Oct 11, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Bone Diseases and Chronic Hepatitis B in HIV Patient and is currently ongoing. Chang Gung Memorial Hospital leads this study, which shows 12 recorded versions since 2018 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshotNot Yet Recruiting~Apr 2018 – ~May 2018 · 30 days · monthly snapshotNot Yet Recruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotNot Yet Recruiting~Aug 2018 – ~Sep 2019 · 13 months · monthly snapshotRecruiting~Sep 2019 – ~Nov 2020 · 14 months · monthly snapshotActive Not Recruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotActive Not Recruiting~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshotUnknown Status~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Dec 2021 — Jul 2024 [monthly]

    Unknown Status

  4. Oct 2021 — Dec 2021 [monthly]

    Unknown Status

    Status: Active Not Recruiting → Unknown Status

  5. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting

▶ Show 7 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  2. Sep 2019 — Nov 2020 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  3. Aug 2018 — Sep 2019 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  4. Jun 2018 — Aug 2018 [monthly]

    Not Yet Recruiting

  5. May 2018 — Jun 2018 [monthly]

    Not Yet Recruiting

  6. Apr 2018 — May 2018 [monthly]

    Not Yet Recruiting

    Phase: NA → None

  7. Mar 2018 — Apr 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chang Gung Memorial Hospital
  • Changhua Christian Hospital
  • Chi Mei Medical Hospital
  • Chung Shan Medical University
  • E-DA Hospital
  • Far Eastern Memorial Hospital
  • Kaohsiung Medical University Chung-Ho Memorial Hospital
  • Kaohsiung Veterans General Hospital.
  • Lotung Poh-Ai Hospital
  • Mackay Memorial Hospital
  • National Cheng-Kung University Hospital
  • National Taiwan University Hospital
  • National Taiwan University Hospital Hsin-Chu Branch
  • National Taiwan University Hospital, Yun-Lin Branch
  • Taichung Veterans General Hospital
  • Taoyuan General Hospital
Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations